A high DOCK2 methylation level was also a significant adverse predictor of BCR-free survival in this cohort (log-rank p = 0.020, Figure 7), thereby confirming our own findings in the Danish RP cohort. This evidence concerns the gene DOCK2 and retinitis pigmentosa 1.